Walter Reed's Zika purified inactivated virus vaccine technology will be transferred to Sanofi. Other researchers are also working on a possible Zika vaccine. Sanofi hopes to produce an effective "killed" vaccine swiftly as another company, Inovio Pharmaceuticals, races to the finish line with its own DNA vaccine. Story highlights Sanofi Pasteur is working on an inactivated vaccine for the Zika virusThe company has not announced a timeline(CNN) Sanofi Pasteur and the Walter Reed Army Institute of Research are joining forces to develop an inoculation against the Zika virus, a mosquito-borne infection that can cause birth defects and other neurological deficits. "We're working on the inactivated vaccine approach, which we think is more directly applicable," said Dr. Jon Heinrichs, Sanofi's R&D project lead for Zika, explaining that his team believes its tactic can produce a vaccine with potency over time.

Source: CNN July 07, 2016 18:22 UTC